Liminatus Pharma (LIMN) executive compensation, 2026 proxy

Chris Kim, Chief Executive Officer, was paid $183,333 in 2025, up 27% from $144,000 the year before.

Open LIMN in Gloom →
Liminatus Pharma's chart, financials and news, free in your browser.Open LIMN in Gloom →
Filed
July 13, 2026
Annual meeting
August 3, 2026
Pay year
2025
Named executives
1
CEO total pay
$183,333+27% vs prior year
Monthly pay from May
$16,667Previously $12,000 monthly
Maximum CEO bonus
100% of salaryBoard discretion
Deferred compensation
$0.21MAt December 31, 2025
Equity plan shares
2,000,000Reserved for awards

How Kim was paid

$183,333 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary100%

Named executive officers

ExecutiveTotal
Chris KimChief Executive Officer$183,333

What changed and why

  • 183,333 CEO salary in 2025 compared with 144,000 in 2024.
  • 16,667 monthly compensation began in May 2025, up from 12,000 monthly through April.
  • 100%100% of salary is the maximum annual bonus the Board may award the CEO.
  • 0.21M0.21 million was deferred compensation owed to the CEO at December 31, 2025.
  • 2,000,000 shares are reserved under the 2025 Omnibus Equity Incentive Plan.
  • No other executive compensation, change-in-control or similar agreements were reported.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.